Brief: Calcimedica Reports Cash And Cash Equivalents Of About $34 Million As Graybug Vision Merger Close Expected To Support Operations Into H2 Of 2024
20/03/2023 20:36
March 20 (Reuters) - Graybug Vision Inc GRAY.O :
* CALCIMEDICA - CASH AND CASH EQUIVALENTS OF ABOUT $34
MILLION AS
GRAYBUG VISION MERGER CLOSE EXPECTED TO SUPPORT OPERATIONS INTO
SECOND HALF OF 2024
* CALCIMEDICA - PHASE 2B RESULTS IN ACUTE PANCREATITIS FOR
LEAD
PRODUCT CANDIDATE AUXORA™ EXPECTED IN Q4 2023
Source text for Eikon: ID:nGNX61mL6y
Further company coverage: GRAY.O
((Reuters.Briefs@thomsonreuters.com;;))